Approval of a clinical trial to assess the safety and performance of Seraph 100 in COVID-19

2021-04-16T07:21:06+00:00March 31st, 2021|ICU|

In Spain, more than 75.000 persons have died of COVID-19, predominantly in densely populated regions like Madrid and Barcelona. The Spanish Agency of Medicines and Medical Devices (Agencia Española de Medicamentos y Productos Sanitarios) has recently authorized the start of a clinical investigation designed to collect data to assess the safety and performance of Seraph® [...]